BioCentury
ARTICLE | Clinical News

Ponesimod: Phase II data

December 24, 2012 8:00 AM UTC

Top-line data from a double-blind, international Phase II trial in 326 patients with moderate to severe chronic plaque psoriasis showed that induction therapy with once-daily 20 and 40 mg oral ponesim...